Nairobi Hospital CEO Allan Pamba was fired on Saturday, October 3, barely six months after walking out of a cushy job in United Kingdom.
The board of the hospital, in a letter, explained that it decided to terminate the contract of the doctor after he failed to execute the mandatory performance improvement plan.
"The letter dated September 10, 2020 extending your probation period up to 12th December 2020 gave you up to September 30, 2020 to acknowledge and execute the performance improvement plan.
“Unfortunately, you responded on September 29, 2020 and requested that the Board of Directors review your performance in line with the Board charter contrary to your letter of appointment which clearly states that the Chairman of the Board will review your performance. Your failure to execute Performance Enhancement Plan and the probation extension letter implied your lack of interest to continue working for The Nairobi hospital," read the document in part.
The firing came just a day after his intimate interview with Business Daily got published in which he confirmed that the company was at a better place with revenue 'slowly climbing.'
"I took this job on the principle of good governance,” he noted during the sit-down.
Pamba is said to have left a 10-year job in UK before accepting to take the reigns at the ailing Nairobi Hospital in March this year.
His stated that his journey into the medical field started right in his childhood, as he often suffered bout of Malaria, and had to make trips to the hospital. Malaria was ranked among the world's biggest killer diseases, every year.
Pamba who was a cattle herder worked hard to emerge fifth countrywide during his year's KCPE exams and proceeded to High School before pursuing a career in medicine.
In 2004, he left for London where after finishing his Master's, he secured a job at GlaxoSmithKline (GSK) and rose to become the vice president of Global Health.
GSK is a science-led global healthcare company that has three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
During his tenure at GSK, the doctor concentrated his research on Malaria and HIV/AIDS which were ravaging the African continent at the time.
The global death toll from malaria alone stood at 400,000 deaths with most affected being children under the age of five from Sub-Saharan Africa.
Pamba has a Master of Science Degree in Public Health and two Bachelor’s degrees in Medicine and Surgery.
